Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
37
ACA Quote, Financials, Valuation and Earnings
Last price:
$98.42
Seasonality move
:
5.13%
Day range:
$96.83 - $101.98
52-week range:
$72.75 - $113.43
Dividend yield:
0.2%
P/E ratio:
37.78x
P/S ratio:
1.95x
P/B ratio:
1.99x
Volume:
570.5K
Avg. volume:
262.4K
1-year change:
22.67%
Market cap:
$4.8B
Revenue:
$2.3B
EPS (TTM):
$2.63
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.9B | $2B | $2.2B | $2.3B | |
| Revenue Growth (YoY) | 18.93% | 11.44% | 5.21% | 10.14% | 2.9% | |
| Cost of Revenues | $1.4B | $1.6B | $1.7B | $1.8B | $1.9B | |
| Gross Profit | $332.4M | $382M | $355.9M | $411.1M | $443.8M | |
| Gross Profit Margin | 19.14% | 19.74% | 17.48% | 18.33% | 19.23% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $179.5M | $223.1M | $256M | $262.8M | $261.1M | |
| Other Inc / (Exp) | -$700K | -$10.5M | $7.1M | $197.8M | $36.6M | |
| Operating Expenses | $179.5M | $223.1M | $256M | $262.8M | $261.1M | |
| Operating Income | $152.9M | $158.9M | $99.9M | $148.3M | $182.7M | |
| Net Interest Expenses | $5.4M | $10.2M | $23.4M | $29.9M | $23.4M | |
| EBT. Incl. Unusual Items | $146.8M | $138.2M | $83.6M | $316.2M | $195.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $33.5M | $31.6M | $14M | $70.4M | $36.7M | |
| Net Income to Company | $113.3M | $106.6M | $69.6M | $245.8M | $159.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $113.3M | $106.6M | $69.6M | $245.8M | $159.2M | |
| Basic EPS (Cont. Ops) | $2.34 | $2.20 | $1.44 | $5.08 | $3.27 | |
| Diluted EPS (Cont. Ops) | $2.32 | $2.18 | $1.42 | $5.05 | $3.26 | |
| Weighted Average Basic Share | $47.9M | $48M | $48.1M | $48.2M | $48.5M | |
| Weighted Average Diluted Share | $48.4M | $48.5M | $48.6M | $48.5M | $48.7M | |
| EBITDA | $239.4M | $263.3M | $251.3M | $501.3M | $383.5M | |
| EBIT | $153.6M | $148.8M | $107M | $347.2M | $224M | |
| Revenue (Reported) | $1.7B | $1.9B | $2B | $2.2B | $2.3B | |
| Operating Income (Reported) | $152.9M | $158.9M | $99.9M | $148.3M | $182.7M | |
| Operating Income (Adjusted) | $153.6M | $148.8M | $107M | $347.2M | $224M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $490M | $559.1M | $603.9M | $591.7M | $640.4M | |
| Revenue Growth (YoY) | 10.11% | 14.1% | 8.01% | -2.02% | 8.23% | |
| Cost of Revenues | $390.3M | $459.1M | $488.8M | $484.6M | $503.7M | |
| Gross Profit | $99.7M | $100M | $115.1M | $107.1M | $136.7M | |
| Gross Profit Margin | 20.35% | 17.89% | 19.06% | 18.1% | 21.35% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $57.6M | $62.5M | $67.8M | $61.3M | $82.4M | |
| Other Inc / (Exp) | $400K | -$100K | $1.9M | $2.2M | -$23.2M | |
| Operating Expenses | $57.6M | $62.5M | $67.8M | $61.3M | $82.4M | |
| Operating Income | $42.1M | $37.5M | $47.3M | $45.8M | $54.3M | |
| Net Interest Expenses | $2.2M | $7.3M | $8.6M | $5M | $12M | |
| EBT. Incl. Unusual Items | $40.3M | $30.1M | $40.6M | $43M | $19.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.1M | $6.4M | $8.6M | $7.5M | $2.5M | |
| Net Income to Company | $31.2M | $23.7M | $32M | $35.5M | $16.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $31.2M | $23.7M | $32M | $35.5M | $16.6M | |
| Basic EPS (Cont. Ops) | $0.64 | $0.49 | $0.66 | $0.73 | $0.34 | |
| Diluted EPS (Cont. Ops) | $0.64 | $0.49 | $0.66 | $0.72 | $0.34 | |
| Weighted Average Basic Share | $48.1M | $48.2M | $48.3M | $48.7M | $48.7M | |
| Weighted Average Diluted Share | $48.5M | $48.6M | $48.5M | $48.8M | $48.8M | |
| EBITDA | $70.8M | $76.4M | $88.8M | $90.2M | $80.1M | |
| EBIT | $42.6M | $37.4M | $49.2M | $49.7M | $34.9M | |
| Revenue (Reported) | $490M | $559.1M | $603.9M | $591.7M | $640.4M | |
| Operating Income (Reported) | $42.1M | $37.5M | $47.3M | $45.8M | $54.3M | |
| Operating Income (Adjusted) | $42.6M | $37.4M | $49.2M | $49.7M | $34.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.9B | $2B | $2.3B | $2.2B | $2.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.5B | $1.6B | $1.9B | $1.8B | $2B | |
| Gross Profit | $375.9M | $360.7M | $410M | $416.8M | $493.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $210.4M | $245.1M | $267.4M | $260.6M | $297.6M | |
| Other Inc / (Exp) | -$600K | -$11.3M | $12.8M | $226.2M | -$3.5M | |
| Operating Expenses | $210.4M | $245.1M | $267.4M | $260.6M | $297.6M | |
| Operating Income | $165.5M | $115.6M | $142.6M | $156.2M | $195.7M | |
| Net Interest Expenses | $9.3M | $18.1M | $30.9M | $23.1M | $36.1M | |
| EBT. Incl. Unusual Items | $155.9M | $86.2M | $124.5M | $359.3M | $156.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $38.7M | $15.3M | $24.1M | $72.6M | $27.6M | |
| Net Income to Company | $117.2M | $70.9M | $100.4M | $286.7M | $128.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $117.2M | $70.9M | $100.4M | $286.7M | $128.5M | |
| Basic EPS (Cont. Ops) | $2.42 | $1.47 | $2.07 | $5.92 | $2.64 | |
| Diluted EPS (Cont. Ops) | $2.40 | $1.45 | $2.05 | $5.88 | $2.63 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $271.5M | $243M | $309.6M | $543.7M | $374.1M | |
| EBIT | $166M | $104.4M | $155.4M | $387.7M | $198.8M | |
| Revenue (Reported) | $1.9B | $2B | $2.3B | $2.2B | $2.5B | |
| Operating Income (Reported) | $165.5M | $115.6M | $142.6M | $156.2M | $195.7M | |
| Operating Income (Adjusted) | $166M | $104.4M | $155.4M | $387.7M | $198.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | $1.5B | $1.7B | $1.7B | $1.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.2B | $1.2B | $1.4B | $1.4B | $1.5B | |
| Gross Profit | $298.3M | $277M | $331.1M | $336.8M | $386.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $163.3M | $185.3M | $196.7M | $194.5M | $231M | |
| Other Inc / (Exp) | $200K | -$400K | $5.3M | $33.7M | -$6.4M | |
| Operating Expenses | $163.3M | $185.3M | $196.7M | $194.5M | $231M | |
| Operating Income | $135M | $91.7M | $134.4M | $142.3M | $155.3M | |
| Net Interest Expenses | $8M | $15.9M | $23.4M | $16.6M | $29.3M | |
| EBT. Incl. Unusual Items | $127.4M | $75.4M | $116.3M | $159.4M | $119.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $31.3M | $15M | $25.1M | $27.3M | $18.2M | |
| Net Income to Company | $96.1M | $60.4M | $91.2M | $132.1M | $101.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $96.1M | $60.4M | $91.2M | $132.1M | $101.4M | |
| Basic EPS (Cont. Ops) | $1.98 | $1.25 | $1.88 | $2.72 | $2.08 | |
| Diluted EPS (Cont. Ops) | $1.97 | $1.24 | $1.86 | $2.70 | $2.07 | |
| Weighted Average Basic Share | $143.8M | $144.3M | $144.8M | $145.5M | $145.8M | |
| Weighted Average Diluted Share | $145.3M | $146M | $145.9M | $146.3M | $146.4M | |
| EBITDA | $218.7M | $198.4M | $256.7M | $299.1M | $289.7M | |
| EBIT | $135.8M | $91.4M | $139.8M | $180.3M | $155.1M | |
| Revenue (Reported) | $1.5B | $1.5B | $1.7B | $1.7B | $1.9B | |
| Operating Income (Reported) | $135M | $91.7M | $134.4M | $142.3M | $155.3M | |
| Operating Income (Adjusted) | $135.8M | $91.4M | $139.8M | $180.3M | $155.1M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $240.4M | $95.8M | $72.9M | $160.4M | $104.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $200M | $260.2M | $310.8M | $334.2M | $357.1M | |
| Inventory | $283.3M | $276.8M | $324.5M | $315.8M | $401.8M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $33.5M | $32.1M | $59.7M | $46.4M | $48.3M | |
| Total Current Assets | $757.2M | $664.9M | $767.9M | $856.8M | $912M | |
| Property Plant And Equipment | $816.2M | $913.3M | $1.2B | $1.2B | $1.3B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $621.9M | $794M | $934.9M | $958.5M | $990.7M | |
| Other Intangibles | $51.7M | $212.9M | $220.3M | $256.1M | $270.7M | |
| Other Long-Term Assets | $41.2M | $46.2M | $49.9M | $60M | $61.4M | |
| Total Assets | $2.3B | $2.6B | $3.2B | $3.3B | $3.6B | |
| Accounts Payable | $90M | $144.1M | $184.7M | $190.7M | $272.5M | |
| Accrued Expenses | $119.4M | $115.2M | $145.9M | $121.8M | $117.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $284M | $310.3M | $364M | $367.7M | $431.2M | |
| Long-Term Debt | $103.6M | $248.2M | $664.7M | $535.9M | $561.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $512.1M | $754.5M | $1.2B | $1.2B | $1.2B | |
| Common Stock | $500K | $500K | $500K | $500K | $500K | |
| Other Common Equity Adj | -$19.7M | -$22.1M | -$19.3M | -$15.7M | -$16.2M | |
| Common Equity | $1.8B | $1.9B | $2B | $2.2B | $2.3B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.8B | $1.9B | $2B | $2.2B | $2.3B | |
| Total Liabilities and Equity | $2.3B | $2.6B | $3.2B | $3.3B | $3.6B | |
| Cash and Short Terms | $240.4M | $95.8M | $72.9M | $160.4M | $104.8M | |
| Total Debt | $107.3M | $254.5M | $679.5M | $550.6M | $568.7M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $189M | $66.1M | $112.2M | $155.3M | $756.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $232.9M | $364.2M | $326.1M | $389.6M | $396.4M | |
| Inventory | $289.9M | $344.5M | $328.8M | $361.2M | $360.4M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $28.8M | $36.1M | $40.9M | $45.4M | $46.1M | |
| Total Current Assets | $740.6M | $810.9M | $922.8M | $951.5M | $1.6B | |
| Property Plant And Equipment | $894.8M | $1.3B | $1.2B | $1.3B | $1.4B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $776M | $932.6M | $958.6M | $966.6M | $1B | |
| Other Intangibles | $163.2M | $222.5M | $261.4M | $247M | $306.3M | |
| Other Long-Term Assets | $45.2M | $47.3M | $57.7M | $60.1M | $93.3M | |
| Total Assets | $2.6B | $3.3B | $3.4B | $3.5B | $4.4B | |
| Accounts Payable | $137.1M | $213.3M | $221.6M | $244.8M | $242.9M | |
| Accrued Expenses | $116.4M | $145.6M | $135.2M | $121.7M | $156M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | $36.7M | -- | -- | |
| Total Current Liabilities | $312.2M | $389.4M | $423.4M | $405.1M | $432.3M | |
| Long-Term Debt | $250.4M | $743.8M | $696.6M | $503.4M | $1.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $753.4M | $1.4B | $1.3B | $1.2B | $1.9B | |
| Common Stock | $500K | $500K | $500K | $500K | $500K | |
| Other Common Equity Adj | -$23M | -$20.2M | -$15.8M | -$16.8M | -$16.7M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.9B | $1.9B | $2B | $2.3B | $2.4B | |
| Total Liabilities and Equity | $2.6B | $3.3B | $3.4B | $3.5B | $4.4B | |
| Cash and Short Terms | $189M | $66.1M | $112.2M | $155.3M | $756.8M | |
| Total Debt | $254.6M | $755.8M | $710.5M | $510.2M | $1.2B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $113.3M | $106.6M | $69.6M | $245.8M | $159.2M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $14.6M | $20M | $18M | $19.1M | $23.9M | |
| Change in Accounts Receivable | $99M | -$13.5M | -$25.9M | -$65.9M | -$47.8M | |
| Change in Inventories | -$22.7M | $32.6M | -$24.6M | -$26.7M | -$83.5M | |
| Cash From Operations | $358.8M | $259.9M | $166.5M | $174.3M | $261M | |
| Capital Expenditures | $85.4M | $82.1M | $85.1M | $138M | $203.5M | |
| Cash Acquisitions | -$32.9M | -$455.7M | -$505.2M | $196.5M | -$118.9M | |
| Cash From Investing | -$109.4M | -$528.2M | -$570.3M | $90.7M | -$285.8M | |
| Dividends Paid (Ex Special Dividend) | -$9.9M | -$9.8M | -$9.8M | -$9.8M | -$9.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $251.4M | $500M | $80M | $160M | |
| Long-Term Debt Repaid | -$81.2M | -$104.9M | -$83.2M | -$220.2M | -$143.8M | |
| Repurchase of Common Stock | -$15.4M | -$11.8M | -$19.5M | -$27.5M | -$25.2M | |
| Other Financing Activities | -$1.9M | -$1.2M | -$6.6M | -- | -$12M | |
| Cash From Financing | -$108.4M | $123.7M | $380.9M | -$177.5M | -$30.8M | |
| Beginning Cash (CF) | $99.4M | $240.4M | $95.8M | $72.9M | $160.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $141M | -$144.6M | -$22.9M | $87.5M | -$55.6M | |
| Ending Cash (CF) | $240.4M | $95.8M | $72.9M | $160.4M | $104.8M | |
| Levered Free Cash Flow | $273.4M | $177.8M | $81.4M | $36.3M | $57.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $31.2M | $23.7M | $32M | $35.5M | $16.6M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $5.2M | $4M | $5.4M | $5.7M | $4.9M | |
| Change in Accounts Receivable | -$7.2M | -$47.5M | $23M | -$3.9M | $35.1M | |
| Change in Inventories | $29.6M | $2.6M | -$21.7M | -$5.8M | $11.2M | |
| Cash From Operations | $106.4M | $25.7M | $71.4M | $43.9M | $135M | |
| Capital Expenditures | $13.3M | $19.3M | $33M | $47.9M | $34.4M | |
| Cash Acquisitions | -$47.8M | -$134.7M | -$100K | -$3.2M | $18.4M | |
| Cash From Investing | -$59.2M | -$150.2M | -$30.8M | -$45.4M | -$9.4M | |
| Dividends Paid (Ex Special Dividend) | -$2.4M | -$2.5M | -$2.4M | -$2.5M | -$2.4M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.1M | $100M | -- | $100M | $735M | |
| Long-Term Debt Repaid | -$3.1M | -$2.3M | -$3.5M | -$136.6M | -$196.8M | |
| Repurchase of Common Stock | -$2.2M | -$4.9M | -$100K | -- | -$100K | |
| Other Financing Activities | -- | -- | -- | -$2M | -$8.2M | |
| Cash From Financing | -$6.6M | $90.3M | -$6M | -$41.1M | $527.5M | |
| Beginning Cash (CF) | $148.4M | $100.3M | $79.4M | $197.9M | $103.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $40.6M | -$34.2M | $34.6M | -$42.6M | $653.1M | |
| Ending Cash (CF) | $189M | $66.1M | $114M | $155.3M | $756.8M | |
| Levered Free Cash Flow | $93.1M | $6.4M | $38.4M | -$4M | $100.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $117.2M | $70.9M | $100.4M | $286.7M | $128.5M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $17.5M | $18.8M | $20.7M | $21.9M | $24.6M | |
| Change in Accounts Receivable | $18M | -$95.5M | -$1M | -$48.5M | -$58.7M | |
| Change in Inventories | $39.9M | -$18.4M | -$27.6M | -$28M | -$10M | |
| Cash From Operations | $366.5M | $110M | $272.3M | $190.5M | $316M | |
| Capital Expenditures | $81.3M | $86M | $110.2M | $196.9M | $195.1M | |
| Cash Acquisitions | -$363.5M | -$617.4M | -$56.9M | $254.8M | -$230.3M | |
| Cash From Investing | -$431.7M | -$687.8M | -$130.5M | $88.7M | -$404.9M | |
| Dividends Paid (Ex Special Dividend) | -$9.8M | -$9.9M | -$9.8M | -$9.7M | -$9.8M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $251.4M | -- | -- | $100M | $995M | |
| Long-Term Debt Repaid | -$104M | -$5.3M | -$138.8M | -$302.4M | -$262M | |
| Repurchase of Common Stock | -$7.8M | -$23.3M | -$25.3M | -$13.8M | -$24.6M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $126.7M | $454.9M | -$93.9M | -$237.9M | $690.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $61.5M | -$122.9M | $47.9M | $41.3M | $601.5M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $285.2M | $24M | $162.1M | -$6.4M | $120.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $96.1M | $60.4M | $91.2M | $132.1M | $101.4M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $14M | $12.8M | $15.5M | $18.3M | $19M | |
| Change in Accounts Receivable | $5.1M | -$76.9M | -$52M | -$34.6M | -$45.5M | |
| Change in Inventories | $14.9M | -$36.1M | -$39.1M | -$40.4M | $33.1M | |
| Cash From Operations | $226.7M | $76.8M | $182.6M | $198.8M | $253.8M | |
| Capital Expenditures | $56.9M | $60.8M | $85.9M | $144.8M | $136.4M | |
| Cash Acquisitions | -$361.7M | -$523.4M | -$75.1M | -$16.8M | -$128.2M | |
| Cash From Investing | -$409.7M | -$569.3M | -$129.5M | -$131.5M | -$250.6M | |
| Dividends Paid (Ex Special Dividend) | -$7.3M | -$7.4M | -$7.4M | -$7.3M | -$7.3M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $251.4M | $500M | $80M | $100M | $935M | |
| Long-Term Debt Repaid | -$103.8M | -$4.2M | -$59.8M | -$142M | -$260.2M | |
| Repurchase of Common Stock | -$7.5M | -$19M | -$24.8M | -$11.1M | -$10.5M | |
| Other Financing Activities | -$1.2M | -$6.6M | -- | -$12M | -$8.2M | |
| Cash From Financing | $131.6M | $462.8M | -$12M | -$72.4M | $648.8M | |
| Beginning Cash (CF) | $589.5M | $278M | $240.9M | $507.5M | $385M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$51.4M | -$29.7M | $41.1M | -$5.1M | $652M | |
| Ending Cash (CF) | $538.1M | $248.3M | $282M | $502.4M | $1B | |
| Levered Free Cash Flow | $169.8M | $16M | $96.7M | $54M | $117.4M | |
Get ACA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ACA
Sector
P/E ratio
37.78x
17.94x
PEG ratio
--
0.34x
P/B ratio
1.99x
1.76x
Price / LTM sales
1.95x
0.97x
Growth Metrics
ACA
Sector
Revenue growth
8.23%
1.77%
Earnings growth
-52.78%
1.67%
Revenue (5-year growth)
9.59%
4.31%
Earnings forecast
$0.85
$0.46
Profitability
ACA
Sector
Profitability FY 2023
$443.8M
$434.2M
Return on invested capital
4.15%
5.93%
Return on assets
3.4%
3.69%
Return on equity
5.41%
8.87%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
21
Estimated Next Earnings Date
Jan
29
Balance Sheet
ACA
Sector
Total cash
$756.8M
$170.4M
Short term investments
--
$46.5M
Total assets
$3.6B
$2.1B
Long term debt
$1.2B
$147.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 1.47% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 10% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 1.24% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
